Healthcare ❯ Pharmaceuticals ❯ Drug Approval ❯ FDA

Novo Nordisk

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

A $149 starter offer alongside a January U.S. launch positions the daily tablet to broaden access.

WHO Elevates GLP-1 Drugs to Essential Medicines as Cardio Data Build and Coverage Battles Escalate